Learning Center
Infusates and VAD Compatibility [virtual]
Includes a Live Web Event on 04/12/2026 at 8:00 AM (EDT)
Vascular access device (VAD) selection is a complex and evolving part of infusion therapy practice. The key foundational concept to VAD selection is vessel health and preservation, selecting the optimal VAD that will support administration of required infusion therapy while maintaining patient safety. It includes 4 basic segments: patient specific assessment and appropriate VAD selection, skilled clinician VAD insertion, VAD management to promote positive outcomes, and analyzing organizational data to identify areas for improvement. The choice of the correct VAD for placement is reliant on thorough understanding of VAD and infusate characteristics within the context of the individual patient’s condition and infusion therapy requirements. This session will review the risks and benefits of VAD options, the infusate components that increase injury risk, then apply those criteria to promote patient safety through to a case-based discussion from various clinical settings.
Learning Objectives: At the conclusion of this session, learners will be able to:
• Describe characteristics of peripheral and central vascular access devices through risk/analysis perspective
• Identify infusate components that increase the risk of patient injury
• Apply VAD and infusate characteristics in a case scenario format to optimize patient safety
Contact Hours: 1
CRNI® RUs: 2
Barb Nickel, APRN-CNS, CCRN, CRNI®
Barb Nickel, APRN-CNS, CCRN, CRNI®, is a Clinical Nurse Specialist at a large health care system in the United States, responsible for staff development and process improvement to optimize outcomes in multiple areas of clinical practice, including critical care, infusion therapy, sepsis, and new graduate transition to practice. Ms Nickel has presented nationally and published in several peer-reviewed journals on infusion-related topics. She was the Chair of the 2024 INS Infusion Therapy Standards of Practice (SOP)Committee, and is now Chair of the 2027 INS SOP Committee. She also serves as Adjunct Research Fellow for Griffith University, Queensland, Australia.
